Optimal Dose of Prophylactic Dexmedetomidine for Preventing Postoperative Shivering.

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

CRIS

Registry ID

KCT0000822

Enrollment

120

Registered

2013-08-16

Start date

2012-08-14

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Drug : Patients were randomly allocated to receive dexmedetomidine in four groups: group S (0.9% normal saline), group D0.5 (dexmedetomidine 0.5 µg/kg), group D0.75 (dexmedetomidine 0.75 µg/kg), group

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: 30~ 60 year-old patients scheduled for elective laparoscopic total hysterectomy, ASA class(American society of anesthesiologists physical status classification) I~II

Exclusion criteria

Exclusion criteria: Obese patients (BMI > 27) and those with hypo- or hyperthyroidism, cardiopulmonary disease, psychological disorders, blood transfusion during surgery, an initial body temperature above 38.0 ? or below 36.0 ? were excluded from the study.

Design outcomes

Primary

Measure	Time frame
postoperative shivering	—

Secondary

Measure	Time frame
sedation;analgesia	—

Countries

Korea, Republic of

Contacts

Public ContactYongshin Kim

The Catholic University of Korea, St. Vincent's Hospital

Outcome results